Update analysis of studies on the MMP-9 −1562 C>T polymorphism and cancer risk

作者: Li-Feng Zhang , Yuan-Yuan Mi , Qiang Cao , Wei Wang , Chao Qin

DOI: 10.1007/S11033-011-1115-5

关键词: Meta-analysisGenetic predispositionGenotypeLung cancerOncologyColorectal cancerProspective cohort studyGenetic modelLower riskInternal medicineBioinformaticsMedicine

摘要: Polymorphisms in the matrix metalloproteinase (MMP) gene have been hypothesized to be functional and may contribute genetic susceptibility cancers. The common sequence variation MMP-9 −1562 C>T (rs3918242), has involved cancer risk. However, results of related published studies were somewhat controversial underpowered general. To clarify role genotype global cancer, we performed a meta-analysis all available involving 4,124 patients 4,728 control subjects. overall indicated that there was no major association variant on stratified analysis by type showed polymorphism lower risk colorectal (OR = 0.80, 95%CI = 0.66–0.96, P heterogeneity = 0.391) lung (OR = 0.70, 95%CI = 0.51–0.96, heterogeneity = 0.959) allelic contrast. Furthermore, also observed hospital-based under dominant model (OR = 0.87, 95%CI = 0.78–0.97, heterogeneity = 0.355), contrast (OR = 0.85, 95%CI = 0.75–0.96, heterogeneity = 0.271) heterozygote comparison (OR = 0.89, 95%CI = 0.79–0.99, heterogeneity = 0.402). This pooled evidence decrease both Further prospective with larger numbers participants worldwide are required evaluate more detail.

参考文章(42)
Sajal Chakraborti, Malay Mandal, Sudip Das, Amritlal Mandal, Tapati Chakraborti, Regulation of matrix metalloproteinases: an overview. Molecular and Cellular Biochemistry. ,vol. 253, pp. 269- 285 ,(2003) , 10.1023/A:1026028303196
Charles, J. Malemud, Matrix metalloproteinases (MMPs) in health and disease: an overview Frontiers in Bioscience. ,vol. 11, pp. 1696- 1701 ,(2006) , 10.2741/1915
Hsi-Feng Tu, Cheng-Hsien Wu, Shou-Yen Kao, Chung-Ji Liu, Tsung-Yun Liu, Man-Tin Lui, Functional −1562 C‐to‐T polymorphism in matrix metalloproteinase‐9 (MMP‐9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users Journal of Oral Pathology & Medicine. ,vol. 36, pp. 409- 414 ,(2007) , 10.1111/J.1600-0714.2007.00552.X
Malay Mandal, Amritlal Mandal, Sudip Das, Tapati Chakraborti, Sajal Chakraborti, Clinical implications of matrix metalloproteinases. Molecular and Cellular Biochemistry. ,vol. 252, pp. 305- 329 ,(2003) , 10.1023/A:1025526424637
Kyung Sook Park, Seon Jeong Kim, Kyung Ho Kim, Jin Cheon Kim, Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer. Journal of Gastroenterology and Hepatology. ,vol. 26, pp. 391- 397 ,(2011) , 10.1111/J.1440-1746.2010.06504.X
Jérôme Rollin, Sandra Régina, Patrick Vourc’h, Sophie Iochmann, Claire Bléchet, Pascale Reverdiau, Yves Gruel, Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer. Lung Cancer. ,vol. 56, pp. 273- 280 ,(2007) , 10.1016/J.LUNGCAN.2006.11.021
Rebecca Gum, Ernst Lengyel, Jose Juarez, Ji Hshiung Chen, Hiroshi Sato, Motoharu Seiki, Douglas Boyd, Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. Journal of Biological Chemistry. ,vol. 271, pp. 10672- 10680 ,(1996) , 10.1074/JBC.271.18.10672
Haixin Lei, Kari Hemminki, Andrea Altieri, Robert Johansson, Kerstin Enquist, Göran Hallmans, Per Lenner, Asta Försti, Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression. Breast Cancer Research and Treatment. ,vol. 103, pp. 61- 69 ,(2007) , 10.1007/S10549-006-9345-2
FJGM Kubben, CFM Sier, MJW Meijer, M Van Den Berg, JJ Van Der Reijden, G Griffioen, CJH Van De Velde, CBHW Lamers, HW Verspaget, Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. British Journal of Cancer. ,vol. 95, pp. 744- 751 ,(2006) , 10.1038/SJ.BJC.6603307